Emerging Therapies Face Development Hurdles: Complex hurdles complicate the development of emerging therapies.

Bibliographic Details
Published in:BioPharm International Vol. 35; no. 5; pp. 10 - 16
Main Author: MIRASOL, FELIZA
Format: pictorial Journal Article
Published: MJH Life Sciences May2022
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156697208&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 156697208
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: May2022
      vid: 35
      iid: 5
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        156697208
        156697208
        156697208
        156697208
      ppf: 10
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Emerging Therapies Face Development Hurdles: Complex hurdles complicate the development of emerging therapies.
      aug:
        au: MIRASOL, FELIZA
      sug:
        subj:
          Drug Development
          Pharmaceutical Companies
          Cell Therapy
          Biological Products
          Gene Therapy
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N